Fig. 13

(A) 3D figure of the proposed binding mode of compound 1 against Human DNA topoisomerase II ATPase target site, amino acids colored by yellow, and the ligand colored by purple. (B) 3D figure of the proposed binding mode of compound 2 against Human DNA topoisomerase II ATPase target site, amino acids colored yellow, and ligand-colored purple.